Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 18945345)

1.

Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties.

Cunningham TJ, Yao L, Lucena A.

J Inflamm (Lond). 2008 Oct 22;5:17. doi: 10.1186/1476-9255-5-17.

2.

Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9.

Cunningham TJ, Maciejewski J, Yao L.

J Neuroinflammation. 2006 Sep 11;3:25.

3.

An essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2.

Yuan Y, Jackson SP, Newnham HH, Mitchell CA, Salem HH.

Blood. 1995 Dec 1;86(11):4166-74.

4.

Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent.

Vlaar AP, Kulik W, Nieuwland R, Peters CP, Tool AT, van Bruggen R, Juffermans NP, de Korte D.

Transfusion. 2011 Nov;51(11):2358-66. doi: 10.1111/j.1537-2995.2011.03177.x. Epub 2011 May 16.

PMID:
21575006
6.

Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis.

Cunningham TJ, Yao L, Oetinger M, Cort L, Blankenhorn EP, Greenstein JI.

J Neuroinflammation. 2006 Sep 11;3:26.

7.

Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis.

Hung ND, Kim MR, Sok DE.

Inflammation. 2011 Jun;34(3):147-60. doi: 10.1007/s10753-010-9218-z.

PMID:
20490641
8.

Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats.

Vlachojannis GJ, Scholz-Pedretti K, Fierlbeck W, Geiger H, Pfeilschifter J, Kaszkin M.

Clin Nephrol. 2005 May;63(5):356-67.

PMID:
15909595
9.

Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients.

Okita M, Gaudette DC, Mills GB, Holub BJ.

Int J Cancer. 1997 Mar 28;71(1):31-4.

PMID:
9096662
10.

Secreted phospholipase A2 involvement in neurodegeneration: differential testing of prosurvival and anti-inflammatory effects of enzyme inhibition.

Chen S, Yao L, Cunningham TJ.

PLoS One. 2012;7(6):e39257. doi: 10.1371/journal.pone.0039257. Epub 2012 Jun 15.

11.

Anti-inflammatory action of arachidonoyl lysophosphatidylcholine or 15-hydroperoxy derivative in zymosan A-induced peritonitis.

Hung ND, Kim MR, Sok DE.

Prostaglandins Other Lipid Mediat. 2009 Dec;90(3-4):105-11. doi: 10.1016/j.prostaglandins.2009.10.001. Epub 2009 Oct 9.

PMID:
19819343
12.

Glucocorticoids suppress basal (but not interleukin-1-supported) ovarian phospholipase A2 activity: evidence for glucocorticoid receptor-mediated regulation.

Kol S, Ben-Shlomo I, Payne DW, Ando M, Rohan RM, Adashi EY.

Mol Cell Endocrinol. 1998 Feb;137(2):117-25.

PMID:
9605513
13.

Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms.

Yokota Y, Hanasaki K, Ono T, Nakazato H, Kobayashi T, Arita H.

Biochim Biophys Acta. 1999 May 18;1438(2):213-22.

PMID:
10320804
14.

Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule.

Nataraju A, Raghavendra Gowda CD, Rajesh R, Vishwanath BS.

Curr Top Med Chem. 2007;7(8):801-9.

PMID:
17456043
15.

Characterization and inhibitor sensitivity of human sperm phospholipase A2: evidence against pivotal involvement of phospholipase A2 in the acrosome reaction.

Anderson RA Jr, Johnson SK, Bielfeld P, Feathergill KA, Zaneveld LJ.

Mol Reprod Dev. 1990 Dec;27(4):305-25.

PMID:
2264993
16.

Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation.

Beck S, Lambeau G, Scholz-Pedretti K, Gelb MH, Janssen MJ, Edwards SH, Wilton DC, Pfeilschifter J, Kaszkin M.

J Biol Chem. 2003 Aug 8;278(32):29799-812. Epub 2003 Jun 2.

17.
18.
19.

Discovery of bioavailable inhibitors of secretory phospholipase A2.

Blanchard SG, Andrews RC, Brown PJ, Gan LS, Lee FW, Sinhababu AK, Wheeler TN.

Pharm Biotechnol. 1998;11:445-63. Review.

PMID:
9760691
20.

Effect of umbelliferone (7-hydroxycoumarin, 7-HOC) on the enzymatic, edematogenic and necrotic activities of secretory phospholipase A2 (sPLA2) isolated from Crotalus durissus collilineatus venom.

Toyama DO, Marangoni S, Diz-Filho EB, Oliveira SC, Toyama MH.

Toxicon. 2009 Mar 15;53(4):417-26. doi: 10.1016/j.toxicon.2008.12.018.

PMID:
19470355
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk